Dimerix (ASX:DXB): This exciting Phase 3 biotech could be about to follow in the footsteps of Telix and Neuren
Dimerix (ASX:DXB) is one of the few ASX biotechs in the middle of a Phase 3 trial, and it even…
Read MoreWhy companies do M&A deals? Here are the 3 most important reasons
In this article we look at why companies do M&A – Mergers and acquisitions. M&A activity is an extremely common…
Read MoreLight And Wonder (ASX:LNW): With PointsBet out of the picture, is this the best way to play the US sports betting market in 2024?
Light And Wonder (ASX:LNW) is now the best way to gain exposure to the US sports betting market on the…
Read More